E2F7 and E2F8 have been reported to be involved in several malignancies such as pancreatic cancer (61), gallbladder cancer (62), colorectal cancer (63, 64), cervical cancer (65), breast cancer (66) and lung cancer (67, 68). This evidence concerns the gene E2F8 and breast cancer.